Explain Wangs motivation for implementing a new logistics process with a third party.

2. Evaluate the existing medical supply chain at Shanghai General Hospital. What are the pain points in the current system? How should Wang respond? 3. Should Wang go ahead with the partnership? Why or why not? 4. Based on Shanghai Pharmaceuticals proposal, describe the nature of the new strategic partnership. What does it offer to improve inventory management? 5. What are the potential risks and challenges of partnering with third party like Shanghai Pharmaceutical? How can Wang manage those risks? 6. Despite the inevitable conflicts of interest between private and public institutions, how can the hospital strategically align shared interests in this partnership? In other words, how can Wang ensure that Shanghai Pharmaceutical has the incentive to effectively manage its inventory?